Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
COO
vs
S&P 500
COO
S&P 500
Over the past 12 months, COO has underperformed S&P 500, delivering a return of -23% compared to S&P 500's +14% growth.
Stocks Performance
COO vs S&P 500
Performance Gap
COO vs S&P 500
Performance By Year
COO vs S&P 500
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Cooper Companies Inc
Glance View
Cooper Companies makes medical products in two main areas: contact lenses and women’s health. Through CooperVision, it sells soft contact lenses for nearsightedness, farsightedness, astigmatism, and presbyopia to eye doctors, optometrists, retailers, and patients. Through CooperSurgical, it sells tools and devices used by fertility clinics, hospitals, and other women’s health providers. The company makes money by manufacturing these products and selling them to healthcare professionals and distributors. A large part of its business comes from recurring use: contact lenses are replaced regularly, and many of its surgical and fertility products are used in ongoing clinical procedures. That gives Cooper a mix of everyday consumer-style demand and professional healthcare demand. What makes Cooper’s business different is that it sits in two specialized niches with long-term customer relationships. In vision care, it focuses on products people need to wear every day, while in women’s health it supplies equipment and consumables used in clinics and hospitals. That combination gives the company a steady role in both routine eye care and specialized medical procedures.